Ram Aiyar, Ph.D., MBA, is the Chief Executive Officer and President of Korro Bio, and sits on the Board of Directors.
Ram brings nearly two decades of diverse experience in biotech and pharma, working across all stages of development from launch to clinical to commercialization. He has a long history of launching and building biotech startups, and previously held a wide range of roles in finance, strategy, product development and venture capital. Most recently, he was a co-founder, chief financial officer and chief business officer at Corvidia Therapeutics, and eventually led its acquisition by Novo Nordisk for $2.1B. Prior to Corvidia, he was an entrepreneur-in-residence at BioHealth Innovation (BHI).
Ram started his scientific career in research at Janssen Pharmaceuticals’ immunology group. He has also held leadership roles in corporate development, finance and strategy at FlowMetric Inc., Sofinnova Partners, and J.P. Morgan Chase.
Ram received his M.S. and Ph.D. in electrical and computer engineering from Drexel University and an MBA in finance and business strategy from INSEAD (France/Singapore).
What is Ram Aiyar's net worth?
The estimated net worth of Ram Aiyar is at least $1.02 million as of May 29th, 2026. Dr. Aiyar owns 74,848 shares of Korro Bio stock worth more than $1,018,457 as of August 10th. This net worth estimate does not reflect any other investments that Dr. Aiyar may own. Learn More about Ram Aiyar's net worth.
How do I contact Ram Aiyar?
Has Ram Aiyar been buying or selling shares of Korro Bio?
Ram Aiyar has not been actively trading shares of Korro Bio over the course of the past ninety days. Most recently, Ram Aiyar sold 15,152 shares of the business's stock in a transaction on Friday, May 29th. The shares were sold at an average price of $12.98, for a transaction totalling $196,672.96. Following the completion of the sale, the chief executive officer now directly owns 74,848 shares of the company's stock, valued at $971,527.04. Learn More on Ram Aiyar's trading history.
Who are Korro Bio's active insiders?
Are insiders buying or selling shares of Korro Bio?
During the last twelve months, Korro Bio insiders bought shares 9 times. They purchased a total of 1,657,320 shares worth more than $18,412,560.00. During the last twelve months, insiders at the sold shares 9 times. They sold a total of 306,026 shares worth more than $4,309,636.75. The most recent insider tranaction occured on July, 6th when Director Jean Francois Formela sold 9,323 shares worth more than $130,149.08. Insiders at Korro Bio own 4.8% of the company.
Learn More about insider trades at Korro Bio. Information on this page was last updated on 7/6/2026.
